Compare Stocks: NDRA, SLNO, ECOR, and IRIX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ECOR electroCore	$8.27 -1.0%	$9.94	$4.41 ▼ $12.70	$74.55M	1.05	87,452 shs	1,312 shs
IRIX IRIDEX	$0.88 +7.0%	$0.74	$0.61 ▼ $1.65	$15.49M	0.67	235,835 shs	6,922 shs
NDRA ENDRA Life Sciences	$4.85 +1.4%	$5.41	$2.96 ▼ $7.55	$7.27M	-0.09	56,118 shs	8,782 shs
SLNO Soleno Therapeutics	$53.01	$47.81	$29.43 ▼ $90.32	$2.76B	-2.22	1.75 million shs	N/A

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ECOR electroCore	+1.83%	-12.20%	-16.92%	+42.01%	+62.45%
IRIX IRIDEX	+0.05%	-8.18%	+30.36%	-11.76%	-22.22%
NDRA ENDRA Life Sciences	+6.69%	-14.00%	-8.93%	+2.20%	-31.17%
SLNO Soleno Therapeutics	0.00%	0.00%	0.00%	0.00%	-21.66%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ECOR electroCore	$8.27 -1.0%	$9.94	$4.41 ▼ $12.70	$74.55M	1.05	87,452 shs	1,312 shs
IRIX IRIDEX	$0.88 +7.0%	$0.74	$0.61 ▼ $1.65	$15.49M	0.67	235,835 shs	6,922 shs
NDRA ENDRA Life Sciences	$4.85 +1.4%	$5.41	$2.96 ▼ $7.55	$7.27M	-0.09	56,118 shs	8,782 shs
SLNO Soleno Therapeutics	$53.01	$47.81	$29.43 ▼ $90.32	$2.76B	-2.22	1.75 million shs	N/A

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ECOR electroCore	+1.83%	-12.20%	-16.92%	+42.01%	+62.45%
IRIX IRIDEX	+0.05%	-8.18%	+30.36%	-11.76%	-22.22%
NDRA ENDRA Life Sciences	+6.69%	-14.00%	-8.93%	+2.20%	-31.17%
SLNO Soleno Therapeutics	0.00%	0.00%	0.00%	0.00%	-21.66%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ECOR electroCore	2.00	Hold	$18.00	115.57% Upside
IRIX IRIDEX	2.00	Hold	$3.00	263.86% Upside
NDRA ENDRA Life Sciences	2.00	Hold	$25.00	390.20% Upside
SLNO Soleno Therapeutics	1.91	Reduce	$65.57	23.70% Upside

Current Analyst Ratings Breakdown

Latest NDRA, SLNO, ECOR, and IRIX Analyst Ratings

Date	Company	Brokerage	Action	Rating
10/14/2026	NDRA ENDRA Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
10/2/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
9/28/2026	NDRA ENDRA Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
9/21/2026	ECOR electroCore	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
9/18/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
9/10/2026	NDRA ENDRA Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
9/4/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
8/21/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
8/13/2026	NDRA ENDRA Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
8/6/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
7/31/2026	NDRA ENDRA Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)

(Data available from 10/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ECOR electroCore	$32.03M	2.35	N/A	N/A	($0.21) per share	-39.76
IRIX IRIDEX	$51.57M	0.28	N/A	N/A	($0.06) per share	-13.74
NDRA ENDRA Life Sciences	N/A	N/A	N/A	N/A	$1.92 per share	N/A
SLNO Soleno Therapeutics	$285.01M	9.69	$0.43 per share	124.10	$9.51 per share	5.57

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ECOR electroCore	-$13.97M	-$1.66	N/A	N/A	N/A	-39.96%	N/A	-81.35%	11/4/2026 (Estimated)
IRIX IRIDEX	-$4.44M	-$0.20	N/A	N/A	N/A	-6.88%	N/A	-12.55%	11/17/2026 (Estimated)
NDRA ENDRA Life Sciences	-$7.03M	-$6.38	N/A	N/A	N/A	N/A	-246.34%	-150.81%	11/13/2026 (Estimated)
SLNO Soleno Therapeutics	$20.89M	$1.77	29.95	9.89	N/A	33.70%	22.85%	18.25%	N/A

Latest NDRA, SLNO, ECOR, and IRIX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/13/2026	Q3 2026	NDRA ENDRA Life Sciences	-$0.84	N/A	N/A	N/A	$0.10 million	N/A
11/4/2026	Q3 2026	ECOR electroCore	-$0.26	N/A	N/A	N/A	$10.93 million	N/A
8/18/2026	Q2 2026	IRIX IRIDEX	-$0.01	-$0.07	-$0.06	-$0.07	$13.59 million	$12.57 million
8/14/2026	Q2 2026	NDRA ENDRA Life Sciences	-$0.84	-$0.63	+$0.21	$0.06	$0.10 million	N/A
8/6/2026	Q2 2026	ECOR electroCore	-$0.4218	-$0.33	+$0.0918	-$0.33	$9.49 million	$9.45 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ECOR electroCore	N/A	N/A	N/A	N/A	N/A
IRIX IRIDEX	N/A	N/A	N/A	N/A	N/A
NDRA ENDRA Life Sciences	N/A	N/A	N/A	N/A	N/A
SLNO Soleno Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ECOR electroCore	N/A	1.21	1.00
IRIX IRIDEX	N/A	1.82	1.08
NDRA ENDRA Life Sciences	N/A	7.10	7.10
SLNO Soleno Therapeutics	0.10	5.62	5.32

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ECOR electroCore	26.74%
IRIX IRIDEX	20.10%
NDRA ENDRA Life Sciences	1.19%
SLNO Soleno Therapeutics	97.42%

Insider Ownership

Company	Insider Ownership
ECOR electroCore	7.80%
IRIX IRIDEX	8.60%
NDRA ENDRA Life Sciences	10.00%
SLNO Soleno Therapeutics	6.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ECOR electroCore	83	9.02 million	8.31 million	Not Optionable
IRIX IRIDEX	108	17.57 million	16.05 million	Optionable
NDRA ENDRA Life Sciences	11	1.50 million	1.35 million	Not Optionable
SLNO Soleno Therapeutics	30	52.12 million	48.78 million	Optionable

NDRA, SLNO, ECOR, and IRIX Headlines

Recent News About These Companies

Kuehn Law Encourages Investors of Soleno Therapeutics, Inc. to Contact Law Firm

September 2, 2026 | prnewswire.com

SLNO 8-DAY DEADLINE ALERT: Hagens Berman Alerts Soleno Therapeutics (SLNO) Investors to Securities Class Action Alleging Hyperphagia Drug Launch Disruptions - Hagens Berman

May 11, 2026 | prnewswire.com

Soleno Merger With Neurocrine Puts Profitability And Valuation In Focus

May 10, 2026 | finance.yahoo.com

SOLENO DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SLNO

May 5, 2026 | newsfilecorp.comN

SOLENO DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SLNO

May 5, 2026 | newsfilecorp.comN

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – SLNO

May 5, 2026 | globenewswire.com

SLNO DEADLINE ALERT: Hagens Berman Alerts Soleno Therapeutics (SLNO) Investors to Today's Lead Plaintiff Deadline in Securities Class Action

May 5, 2026 | prnewswire.com

DEADLINE ALERT for EOSE, SLNO, and NKTR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

May 5, 2026 | globenewswire.com

SLNO Shareholder Alert: Soleno Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm

May 5, 2026 | prnewswire.com

Portnoy Law Firm Announces Class Action on Behalf of Soleno Therapeutics, Inc. Investors

May 5, 2026 | globenewswire.com

SOLENO THERAPEUTICS DEADLINE TOMORROW: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SLNO

May 4, 2026 | newsfilecorp.comN

SOLENO THERAPEUTICS CLASS ACTION DEADLINE TOMORROW: Bragar Eagel & Squire, P.C. Urges Soleno Therapeutics, Inc. Investors with Significant Losses to Contact the Firm Before May 5th Lead Plaintiff Deadline

May 4, 2026 | globenewswire.com

Deadline Soon: Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

May 4, 2026 | tmcnet.com

SOLENO THERAPEUTICS DEADLINE TOMORROW: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNO

May 4, 2026 | globenewswire.com

SLNO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026

May 4, 2026 | newsfilecorp.comN

Bronstein, Gewirtz & Grossman LLC Urges Soleno Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

May 4, 2026 | globenewswire.com

SLNO Deadline: SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit

May 4, 2026 | prnewswire.com

SLNO SHAREHOLDER NOTICE: Hagens Berman Alerts Soleno (SLNO) Investors to Pending Securities Fraud Class Action and Upcoming May 5th Lead Plaintiff Deadline

May 4, 2026 | globenewswire.com

Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO

May 4, 2026 | prnewswire.com

SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

May 4, 2026 | prnewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

NDRA, SLNO, ECOR, and IRIX Company Descriptions

electroCore NASDAQ:ECOR

$8.26 -0.09 (-1.02%)

As of 10:02 AM Eastern

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

IRIDEX NASDAQ:IRIX

$0.88 +0.06 (+6.97%)

As of 10:00 AM Eastern

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

ENDRA Life Sciences NASDAQ:NDRA

$4.84 +0.07 (+1.36%)

As of 10:02 AM Eastern

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Soleno Therapeutics NASDAQ:SLNO

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NDRA, SLNO, ECOR, and IRIX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NDRA, SLNO, ECOR, and IRIX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NDRA, SLNO, ECOR, and IRIX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

NDRA, SLNO, ECOR, and IRIX Company Descriptions

electroCore NASDAQ:ECOR

IRIDEX NASDAQ:IRIX

ENDRA Life Sciences NASDAQ:NDRA

Soleno Therapeutics NASDAQ:SLNO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NDRA, SLNO, ECOR, and IRIX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NDRA, SLNO, ECOR, and IRIX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NDRA, SLNO, ECOR, and IRIX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

NDRA, SLNO, ECOR, and IRIX Company Descriptions

electroCore NASDAQ:ECOR

IRIDEX NASDAQ:IRIX

ENDRA Life Sciences NASDAQ:NDRA

Soleno Therapeutics NASDAQ:SLNO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools